CCL5 and hepatocellular carcinoma: The binding of RANTES to its specific GPCR or to heparan sulfate proteoglycans resulted in the migration of human hepatoma cells or endothelial cells11–13. RANTES has been detected in plasma samples of patients with cardiovascular diseases14 and is involved in cardiac inflammatory disorders after organ transplantation or arterial injury15.